We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$684M
AUM Growth
+$191M
Cap. Flow
+$175M
Cap. Flow %
25.54%
Top 10 Hldgs %
22.29%
Holding
1,116
New
453
Increased
148
Reduced
137
Closed
375

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$66.9M
2
TSLA icon
Tesla
TSLA
+$17M
3
SBUX icon
Starbucks
SBUX
+$7.73M
4
BABA icon
Alibaba
BABA
+$5.61M
5
FERG icon
Ferguson
FERG
+$5.09M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$8.46M
2
UPS icon
United Parcel Service
UPS
+$6.5M
3
MDT icon
Medtronic
MDT
+$5.4M
4
PANW icon
Palo Alto Networks
PANW
+$5.27M
5
MMM icon
3M
MMM
+$4.22M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 15.35%
3 Healthcare 11.88%
4 Financials 8.41%
5 Industrials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
1001
Revolution Medicines
RVMD
$40B
-10,000
Closed -$197K
S icon
1002
SentinelOne
S
$6.22B
-54,700
Closed -$1.4M
SAFE
1003
Safehold
SAFE
$1.19B
-3,752
Closed -$169K
SAGE
1004
DELISTED
Sage Therapeutics
SAGE
-6,800
Closed -$266K
SAH icon
1005
Sonic Automotive
SAH
$3.25B
-6,104
Closed -$264K
SBLK icon
1006
Star Bulk Carriers
SBLK
$3.02B
-24,567
Closed -$429K
SBRA icon
1007
Sabra Healthcare REIT
SBRA
$5.65B
-17,100
Closed -$224K
SG icon
1008
Sweetgreen
SG
$733M
-30,300
Closed -$561K
SHLS icon
1009
Shoals Technologies Group
SHLS
$1.57B
-13,460
Closed -$290K
SIDU icon
1010
Sidus Space
SIDU
$180M
-105
Closed -$22K
SJM icon
1011
J.M. Smucker
SJM
$12.9B
-4,600
Closed -$632K
SKX
1012
DELISTED
Skechers
SKX
-18,070
Closed -$573K
SLDP icon
1013
Solid Power
SLDP
$481M
-56,700
Closed -$298K
SLF icon
1014
Sun Life Financial
SLF
$46B
-7,024
Closed -$279K
SM icon
1015
SM Energy
SM
$7.26B
-15,364
Closed -$578K
SMH icon
1016
VanEck Semiconductor ETF
SMH
$66.1B
-3,194
Closed -$296K
SOPA
1017
DELISTED
Society Pass
SOPA
-847
Closed -$20K
SPWH icon
1018
Sportsman's Warehouse
SPWH
$44.9M
-11,331
Closed -$94K
SRPT icon
1019
Sarepta Therapeutics
SRPT
$1.68B
-8,140
Closed -$900K
ST icon
1020
Sensata Technologies
ST
$6.75B
-45,900
Closed -$1.71M
STM icon
1021
STMicroelectronics
STM
$47.7B
-28,900
Closed -$894K
STZ icon
1022
Constellation Brands
STZ
$22.2B
-1,927
Closed -$443K
SU icon
1023
Suncor Energy
SU
$75.6B
-26,700
Closed -$752K
SWBI icon
1024
Smith & Wesson
SWBI
$666M
-21,056
Closed -$218K
TCOM icon
1025
Trip.com Group
TCOM
$28.2B
-14,321
Closed -$391K

Similar funds

Bayesian Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Bayesian Capital Management held 1,116 positions worth $684M, up 39% from $493M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Bayesian Capital Management deployed $175M of net new capital in Q4 2022, opening 453 new positions and adding to 148 existing holdings. Its largest new stake was Tesla: 89,769 shares worth $11.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $5.4M trimmed.

  • Bayesian Capital Management's largest Q4 2022 buy was Tesla: 89,769 shares worth $11.1M.
  • Bayesian Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $66.9M increase.
  • Bayesian Capital Management's biggest Q4 2022 reduction was Medtronic, cutting an estimated $5.4M.
  • Bayesian Capital Management fully exited Micron Technology in Q4 2022, selling an estimated $8.46M.
  • Bayesian Capital Management's ten largest holdings make up 22% of its $684M portfolio in Q4 2022.
  • Bayesian Capital Management opened 453 new positions and closed 375 in Q4 2022.
  • Bayesian Capital Management's portfolio value rose 39% quarter-over-quarter to $684M.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.